We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+20.24%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$216M
AUM Growth
-$32M
Cap. Flow
-$54.4M
Cap. Flow %
-25.19%
Top 10 Hldgs %
70.66%
Holding
99
New
11
Increased
15
Reduced
20
Closed
12

Top Buys

Rank Stock Value
1
COGT icon
Cogent Biosciences
COGT
+$2.87M
2
ALKS icon
Alkermes
ALKS
+$2.27M
3
MRSN
Mersana Therapeutics
MRSN
+$2.12M
4
TGTX icon
TG Therapeutics
TGTX
+$1.47M
5
BHVN icon
Biohaven
BHVN
+$1.37M

Top Sells

Rank Stock Value
1
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$17.4M
2
CLMT icon
Calumet Specialty Products
CLMT
+$11.7M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.96M
4
AVDL
Avadel Pharmaceuticals
AVDL
+$5.54M
5
VRNA
Verona Pharma
VRNA
+$4.09M

Sector Composition

Rank Sector Weight
1 Healthcare 41.34%
2 Materials 20.5%
3 Financials 18.92%
4 Communication Services 13.33%
5 Technology 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
51
Ultragenyx Pharmaceutical
RARE
$2.52B
$460K 0.21%
20,006
-31,994
-62% -$1.05M
MRSN
52
DELISTED
Mersana Therapeutics
MRSN
$438K 0.2%
+111,686
New +$2.12M
KURA icon
53
Kura Oncology
KURA
$834M
$407K 0.19%
39,209
-28,093
-42% -$295K
FATE icon
54
Fate Therapeutics
FATE
$265M
$359K 0.17%
365,000
– –
JSPR icon
55
Jasper Therapeutics
JSPR
$20.6M
$332K 0.15%
181,389
+10,000
+6% +$20.1K
IVVD icon
56
Invivyd
IVVD
$175M
$247K 0.11%
100,000
– –
AVGO icon
57
Broadcom
AVGO
$1.8T
$246K 0.11%
710
– –
KMB icon
58
Kimberly-Clark
KMB
$38.1B
$242K 0.11%
2,400
-3,600
-60% -$394K
DAWN
59
DELISTED
Day One Biopharmaceuticals
DAWN
$241K 0.11%
25,884
-104,616
-80% -$874K
NVDA icon
60
NVIDIA
NVDA
$4.77T
$239K 0.11%
1,280
– –
RHP icon
61
Ryman Hospitality Properties
RHP
$8.45B
$227K 0.11%
2,400
-9,600
-80% -$887K
MDLZ icon
62
Mondelez International
MDLZ
$81B
$161K 0.07%
3,000
-5,000
-63% -$288K
DD icon
63
DuPont de Nemours
DD
$19.1B
$151K 0.07%
1,256
-6,247
-83% -$703K
MREO
64
Mereo BioPharma
MREO
$47.4M
$125K 0.06%
300,337
– –
CNTA
65
DELISTED
Centessa Pharmaceuticals
CNTA
$100K 0.05%
+4,000
New +$101K
QURE icon
66
uniQure
QURE
$2.54B
$95.7K 0.04%
4,000
+2,000
+100% +$77.2K
IWP icon
67
iShares Russell Mid-Cap Growth ETF
IWP
$19.5B
$95.2K 0.04%
+695
New +$97.1K
GOOGL icon
68
Alphabet (Google) Class A
GOOGL
$4.02T
$93.9K 0.04%
300
– –
EBC icon
69
Eastern Bankshares
EBC
$5.33B
$92.2K 0.04%
5,000
– –
CTVA icon
70
Corteva
CTVA
$59.6B
$80.8K 0.04%
1,206
-9,845
-89% -$637K
LEGH icon
71
Legacy Housing
LEGH
$634M
$78.1K 0.04%
4,000
– –
PWR icon
72
Quanta Services
PWR
$86.8B
$74.3K 0.03%
176
– –
AMZN icon
73
Amazon
AMZN
$2.46T
$69.2K 0.03%
300
– –
URI icon
74
United Rentals
URI
$70.4B
$63.1K 0.03%
78
– –
FSK icon
75
FS KKR Capital
FSK
$3.04B
$42.6K 0.02%
2,875
– –
1 2
3
4

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return
IWA
Integrity Wealth Advisors Ventura, California $168M AUM 18.33% 1-Year Est. Return

David M. Knott Jr's Q4 2025 Portfolio in Review

As of Q4 2025, David M. Knott Jr held 99 positions worth $216M, down 13% from $248M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

David M. Knott Jr withdrew a net $54.4M in Q4 2025, closing 12 positions and reducing 20 holdings. Its most notable exit was Avadel Pharmaceuticals, an estimated $5.54M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 35% a quarter earlier, followed by Materials and Financials.

Against the trend, David M. Knott Jr opened a new position in Cogent Biosciences worth $3.62M.

  • David M. Knott Jr's largest Q4 2025 buy was Cogent Biosciences: 102,000 shares worth $3.62M.
  • David M. Knott Jr added most to Alkermes in Q4 2025, an estimated $2.27M increase.
  • David M. Knott Jr's biggest Q4 2025 reduction was Janus Henderson AAA CLO ETF, cutting an estimated $17.4M.
  • David M. Knott Jr fully exited Avadel Pharmaceuticals in Q4 2025, selling an estimated $5.54M.
  • David M. Knott Jr's ten largest holdings make up 71% of its $216M portfolio in Q4 2025.
  • David M. Knott Jr opened 11 new positions and closed 12 in Q4 2025.
  • David M. Knott Jr's portfolio value fell 13% quarter-over-quarter to $216M.

Based on David M. Knott Jr's 13F filing for Q4 2025, filed 12 Feb 2026.